These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30587614)

  • 1. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
    Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
    In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitinase-3-like Protein 1 (YKL-40): Novel Biomarker of Hidradenitis Suppurativa Disease Activity?
    Matusiak Ł; Salomon J; Nowicka-Suszko D; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2015 Jul; 95(6):736-7. PubMed ID: 25655759
    [No Abstract]   [Full Text] [Related]  

  • 4. MCPIP1/Regnase-1 Expression in Keratinocytes of Patients with Hidradenitis Suppurativa: Preliminary Results.
    Krajewski PK; Szukała W; Lichawska-Cieślar A; Matusiak Ł; Jura J; Szepietowski JC
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.
    Vossen ARJV; van der Zee HH; Davelaar N; Mus AMC; van Doorn MBA; Prens EP
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):761-765. PubMed ID: 30451329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
    Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
    Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
    Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
    Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
    Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
    Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
    Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
    Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous PGP 9.5 distribution patterns in hidradenitis suppurativa.
    Sartorius K; Emtestam L; Lapins J; Johansson O
    Arch Dermatol Res; 2010 Aug; 302(6):461-8. PubMed ID: 20091410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
    Hessam S; Sand M; Skrygan M; Bechara FG
    Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents.
    Matusiak Ł; Szczęch J; Bieniek A; Nowicka-Suszko D; Szepietowski JC
    J Am Acad Dermatol; 2017 Apr; 76(4):670-675. PubMed ID: 28041632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
    Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.
    Hoffman LK; Tomalin LE; Schultz G; Howell MD; Anandasabapathy N; Alavi A; Suárez-Fariñas M; Lowes MA
    PLoS One; 2018; 13(9):e0203672. PubMed ID: 30265680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
    Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
    J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitinase-3-like Protein 1 (YKL-40) Expression in Squamous Cell Skin Cancer.
    Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
    Anticancer Res; 2018 Aug; 38(8):4753-4758. PubMed ID: 30061245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.